Back to search

Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism

Data up to Jan 2025

Published2006
Citations119
References29

Total Citations Per Year

Abstract

References (29)

American Urological Association Guideline On The Management of Priapism

2003 • 579 citations

Pharmacology of penile erection.

2001 • 521 citations

Phosphorylation of phosphodiesterase‐5 by cyclic nucleotide‐dependent protein kinase alters its catalytic and allosteric cGMP‐binding activities

2000 • 273 citations

Priapism in sickle‐cell disease; incidence, risk factors and complications – an international multicentre study

2002 • 261 citations

Phosphodiesterase-5A dysregulation in penile erectile tissue is a mechanism of priapism

2005 • 241 citations

Regulation of cGMP-specific Phosphodiesterase (PDE5) Phosphorylation in Smooth Muscle Cells

2002 • 216 citations

Priapism and Impotence in Homozygous Sickle Cell Disease

1980 • 212 citations

Priapism: A Refined Approach to Diagnosis and Treatment

1986 • 210 citations

Inhibition of Cyclic GMP-Binding Cyclic GMP-Specific Phosphodiesterase (Type 5) by Sildenafil and Related Compounds

1999 • 193 citations

Priapism in Sickle Cell Disease

2005 • 171 citations

Priapism Associated With the Sickle Cell Hemoglobinopathies: Prevalence, Natural History and Sequelae

1991 • 167 citations

Priapism; Reasons for Failure of Therapy

1960 • 164 citations

Experience with 105 Patients with Priapism: Update Review of All Aspects

1988 • 161 citations

Novel nitric oxide signaling mechanisms regulate the erectile response

2004 • 151 citations

Noncholinergic Penile Erection in Mice Lacking the Gene for Endothelial Nitric Oxide Synthase

2002 • 113 citations

Human PDE5A gene encodes three PDE5 isoforms from two alternate promoters

2002 • 95 citations

Pathophysiology of Priapism: Dysregulatory Erection Physiology Thesis.

2003 • 94 citations

Lecture 3

2001 • 93 citations

Phosphorylation of Isolated Human Phosphodiesterase-5 Regulatory Domain Induces an Apparent Conformational Change and Increases cGMP Binding Affinity

2002 • 93 citations

Erection Capability Is Potentiated by Long-Term Sildenafil Treatment: Role of Blood Flow-Induced Endothelial Nitric-Oxide Synthase Phosphorylation

2005 • 89 citations

Allosteric sites of phosphodiesterase‐5 (PDE5)

2001 • 88 citations

Up and Down-Regulation of Phosphodiesterase-5 as Related to Tachyphylaxis and Priapism

2003 • 78 citations

Recurrent Prolonged Erections and Priapism as a Sequela of Priapism: Pathophysiology and Management

1991 • 66 citations

High Flow Priapism Associated with Sickle Cell Disease

1995 • 58 citations

Allosteric Activation of cGMP-Specific, cGMP-Binding Phosphodiesterase (PDE5) by cGMP

2002 • 52 citations

Priapism

2000 • 46 citations

HYDROXYUREA IN THE TREATMENT OF SICKLE CELL ASSOCIATED PRIAPISM

1998 • 40 citations

High-flow priapism associated with Fabry's disease in a child: A case report and review of the literature

1996 • 34 citations

Allosteric sites of phosphodiesterase-5 sequester cyclic GMP

2004 • 19 citations

Cited By (0)

No citing papers found in database

Long-term oral phosphodiesterase 5 inhibitor therapy alleviates recurrent priapism (2006) – Urology | Metascience Observatory Explorer